Published in Women's Health Law Weekly, October 2nd, 2005
According to recent research from Germany, "Expansion of hematopoietic progenitor cells (HPC) in the presence of endothelium has been shown to result in grafts capable of restoring hematopoiesis in a myeloablated host. However, the use of xenogeneic endothelium or cell lines may carry risks in a clinical transplantation setting."
"We explored the feasibility of cord blood progenitor cell expansion in vitro in an autologous coculture...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly